Artal Group as of Dec. 31, 2020
Portfolio Holdings for Artal Group
Artal Group holds 127 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ww Intl (WW) | 7.8 | $362M | 15M | 24.40 | |
Seer Com Cl A (SEER) | 7.0 | $328M | 5.8M | 56.14 | |
Beigene Sponsored Adr (BGNE) | 5.5 | $258M | 1.0M | 258.39 | |
Lexicon Pharmaceuticals Com New (LXRX) | 5.2 | $243M | 71M | 3.42 | |
Acceleron Pharma | 3.8 | $179M | 1.4M | 127.94 | |
Alnylam Pharmaceuticals (ALNY) | 2.8 | $130M | 1.0M | 129.97 | |
Fate Therapeutics (FATE) | 2.7 | $127M | 1.4M | 90.93 | |
Mirati Therapeutics | 2.4 | $110M | 500k | 219.64 | |
Igm Biosciences (IGMS) | 2.3 | $106M | 1.2M | 88.29 | |
Scholar Rock Hldg Corp (SRRK) | 2.2 | $102M | 2.1M | 48.53 | |
GDS HLDGS Sponsored Ads (GDS) | 2.0 | $94M | 1.0M | 93.64 | |
Alibaba Group Hldg Sponsored Ads (BABA) | 2.0 | $93M | 400k | 232.73 | |
Allovir (ALVR) | 1.9 | $89M | 2.3M | 38.44 | |
Argenx Se Sponsored Adr (ARGX) | 1.9 | $88M | 300k | 294.09 | |
Abbvie Call Option (ABBV) | 1.8 | $86M | 800k | 107.15 | |
Biontech Se Sponsored Ads (BNTX) | 1.8 | $82M | 1.0M | 81.52 | |
Amicus Therapeutics (FOLD) | 1.7 | $81M | 3.5M | 23.09 | |
Generation Bio (GBIO) | 1.7 | $80M | 2.8M | 28.35 | |
Tg Therapeutics (TGTX) | 1.7 | $78M | 1.5M | 52.02 | |
Zillow Group Cl C Cap Stk (Z) | 1.5 | $71M | 550k | 129.80 | |
Schrodinger (SDGR) | 1.4 | $63M | 797k | 79.18 | |
Bristol Myers Squibb Call Option (BMY) | 1.3 | $62M | 1.0M | 62.03 | |
Ke Hldgs Sponsored Ads (BEKE) | 1.3 | $62M | 1.0M | 61.54 | |
Morphic Hldg (MORF) | 1.2 | $55M | 1.7M | 33.55 | |
Atara Biotherapeutics (ATRA) | 1.2 | $55M | 2.8M | 19.63 | |
Black Diamond Therapeutics (BDTX) | 1.1 | $53M | 1.6M | 32.05 | |
Sqz Biotech (SQZB) | 1.0 | $47M | 1.6M | 28.98 | |
Turning Point Therapeutics I | 0.9 | $43M | 350k | 121.85 | |
Praxis Precision Medicines I | 0.9 | $41M | 750k | 55.02 | |
Chemocentryx | 0.9 | $40M | 650k | 61.92 | |
Kronos Bio (KRON) | 0.8 | $39M | 1.3M | 29.87 | |
Cerevel Therapeutics Hldng I (CERE) | 0.8 | $38M | 2.3M | 16.58 | |
Iteos Therapeutics (ITOS) | 0.8 | $37M | 1.1M | 33.82 | |
Foghorn Therapeutics (FHTX) | 0.7 | $35M | 1.7M | 20.27 | |
Sage Therapeutics (SAGE) | 0.7 | $35M | 400k | 86.51 | |
I Mab Sponsored Ads (IMAB) | 0.7 | $34M | 725k | 47.15 | |
Denali Therapeutics (DNLI) | 0.7 | $34M | 400k | 83.76 | |
Springworks Therapeutics (SWTX) | 0.7 | $33M | 450k | 72.52 | |
Mersana Therapeutics (MRSN) | 0.7 | $32M | 1.2M | 26.61 | |
Trillium Therapeutics Com New | 0.7 | $31M | 2.1M | 14.71 | |
Rubius Therapeutics | 0.6 | $29M | 3.8M | 7.59 | |
Deciphera Pharmaceuticals (DCPH) | 0.6 | $29M | 500k | 57.07 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.6 | $28M | 1.0M | 26.54 | |
Adverum Biotechnologies | 0.6 | $27M | 2.5M | 10.84 | |
Replimune Group (REPL) | 0.6 | $27M | 700k | 38.15 | |
Albireo Pharma | 0.6 | $26M | 700k | 37.51 | |
Alx Oncology Hldgs (ALXO) | 0.6 | $26M | 300k | 86.20 | |
Uniqure Nv SHS (QURE) | 0.5 | $25M | 700k | 36.13 | |
Novagold Res Com New (NG) | 0.5 | $25M | 2.6M | 9.67 | |
Gossamer Bio (GOSS) | 0.5 | $23M | 2.4M | 9.67 | |
Translate Bio | 0.5 | $22M | 1.2M | 18.43 | |
Agenus Com New (AGEN) | 0.5 | $22M | 6.9M | 3.18 | |
Schlumberger Call Option (SLB) | 0.5 | $22M | 1.0M | 21.83 | |
Bridgebio Pharma (BBIO) | 0.5 | $21M | 300k | 71.11 | |
Kura Oncology (KURA) | 0.4 | $20M | 600k | 32.66 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $20M | 570k | 34.30 | |
Bio-techne Corporation (TECH) | 0.4 | $19M | 60k | 317.55 | |
Iovance Biotherapeutics (IOVA) | 0.4 | $19M | 400k | 46.40 | |
Forma Therapeutics Hldgs SHS | 0.4 | $18M | 500k | 34.90 | |
Trip Com Group Ads (TCOM) | 0.4 | $17M | 500k | 33.73 | |
Relay Therapeutics (RLAY) | 0.4 | $17M | 400k | 41.56 | |
Zymeworks | 0.4 | $17M | 350k | 47.26 | |
Nanobiotix Sa Sponsored Ads (NBTX) | 0.4 | $17M | 1.0M | 16.50 | |
Cardiff Oncology (CRDF) | 0.3 | $16M | 900k | 17.99 | |
Kymera Therapeutics (KYMR) | 0.3 | $16M | 250k | 62.00 | |
Stoke Therapeutics (STOK) | 0.3 | $16M | 250k | 61.93 | |
Tcr2 Therapeutics Inc cs | 0.3 | $16M | 500k | 30.93 | |
Iqiyi Sponsored Ads (IQ) | 0.3 | $15M | 850k | 17.48 | |
Fibrogen (FGEN) | 0.3 | $15M | 400k | 37.09 | |
Curis Com New | 0.3 | $15M | 1.8M | 8.19 | |
Bellus Health Com New | 0.3 | $15M | 4.8M | 3.06 | |
Krystal Biotech (KRYS) | 0.3 | $14M | 238k | 60.00 | |
Y Mabs Therapeutics (YMAB) | 0.3 | $14M | 285k | 49.51 | |
Aurinia Pharmaceuticals (AUPH) | 0.3 | $14M | 1.0M | 13.83 | |
Selecta Biosciences (RNAC) | 0.3 | $14M | 4.5M | 3.03 | |
Intellia Therapeutics (NTLA) | 0.3 | $14M | 250k | 54.40 | |
Harpoon Therapeutics | 0.3 | $13M | 800k | 16.61 | |
Sigilon Therapeutics | 0.3 | $13M | 276k | 48.03 | |
BioMarin Pharmaceutical Call Option (BMRN) | 0.3 | $13M | 150k | 87.69 | |
Olema Pharmaceuticals (OLMA) | 0.3 | $13M | 261k | 48.08 | |
Danaher Corporation (DHR) | 0.2 | $11M | 50k | 222.14 | |
Immunic (IMUX) | 0.2 | $11M | 700k | 15.29 | |
Hookipa Pharma Inc equity (HOOK) | 0.2 | $11M | 950k | 11.09 | |
Cytokinetics Com New (CYTK) | 0.2 | $10M | 500k | 20.78 | |
Spero Therapeutics (SPRO) | 0.2 | $9.7M | 500k | 19.39 | |
Bruker Corporation (BRKR) | 0.2 | $9.5M | 175k | 54.13 | |
Aptinyx | 0.2 | $8.7M | 2.5M | 3.46 | |
Evelo Biosciences | 0.2 | $8.5M | 700k | 12.09 | |
Applied Therapeutics (APLT) | 0.2 | $8.4M | 380k | 22.01 | |
Aeglea Biotherapeutics | 0.2 | $8.2M | 1.0M | 7.87 | |
Syros Pharmaceuticals | 0.2 | $8.1M | 750k | 10.85 | |
American Airls Call Option (AAL) | 0.2 | $7.9M | 500k | 15.77 | |
Alpine Immune Sciences (ALPN) | 0.2 | $7.5M | 593k | 12.60 | |
Aravive | 0.2 | $7.4M | 1.3M | 5.64 | |
Metacrine Ord | 0.2 | $7.3M | 925k | 7.86 | |
Celldex Therapeutics Com New (CLDX) | 0.2 | $7.0M | 400k | 17.52 | |
111 Ads (YI) | 0.1 | $7.0M | 1.0M | 6.95 | |
Leap Therapeutics | 0.1 | $6.8M | 3.0M | 2.25 | |
Dyne Therapeutics (DYN) | 0.1 | $6.3M | 300k | 21.00 | |
Ovid Therapeutics (OVID) | 0.1 | $5.8M | 2.5M | 2.31 | |
Cyclerion Therapeutics | 0.1 | $5.4M | 1.8M | 2.99 | |
Moderna (MRNA) | 0.1 | $5.2M | 50k | 104.48 | |
Ac Immune Sa SHS (ACIU) | 0.1 | $5.2M | 1.0M | 5.17 | |
Contrafect Corp Com New | 0.1 | $5.1M | 1.0M | 5.05 | |
Proqr Therapeutics N V Shs Euro (PRQR) | 0.1 | $5.0M | 1.2M | 4.20 | |
Kinnate Biopharma (KNTE) | 0.1 | $5.0M | 125k | 39.78 | |
Seres Therapeutics (MCRB) | 0.1 | $4.9M | 200k | 24.50 | |
Kaleido Biosciences Ord (KLDO) | 0.1 | $4.6M | 501k | 9.10 | |
Axcella Health Inc equity | 0.1 | $3.7M | 713k | 5.19 | |
Yumanity Therapeutics | 0.1 | $3.7M | 217k | 17.00 | |
Marinus Pharmaceuticals Com New (MRNS) | 0.1 | $3.7M | 300k | 12.20 | |
Avidity Biosciences Ord (RNA) | 0.1 | $3.6M | 143k | 25.52 | |
Oric Pharmaceuticals (ORIC) | 0.1 | $3.4M | 100k | 33.85 | |
Adc Therapeutics Sa SHS (ADCT) | 0.1 | $3.0M | 95k | 32.01 | |
Chinook Therapeutics | 0.1 | $2.9M | 181k | 15.86 | |
Protagonist Therapeutics (PTGX) | 0.1 | $2.7M | 133k | 20.16 | |
Mei Pharma Com New | 0.0 | $2.0M | 760k | 2.64 | |
Select Sector Spdr Tr Energy Call Option (XLE) | 0.0 | $1.9M | 50k | 37.90 | |
Idera Pharmaceuticals Com Par | 0.0 | $1.8M | 500k | 3.67 | |
Adicet Bio (ACET) | 0.0 | $1.8M | 129k | 14.05 | |
Chiasma | 0.0 | $1.7M | 380k | 4.35 | |
Orchard Therapeutics Ads | 0.0 | $1.5M | 352k | 4.32 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.3M | 111k | 11.38 | |
Rigel Pharmaceuticals Com New (RIGL) | 0.0 | $1.1M | 321k | 3.50 | |
Surface Oncology | 0.0 | $924k | 100k | 9.24 | |
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.0 | $450k | 80k | 5.65 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $449k | 225k | 2.00 |